Mediclinic, the South Africa-based multinational hospital group, has granted due diligence access to the consortium which has made a bid proposal valuing Mediclinic at 504 pence per share, a rise of just 8.8% on the previous offer of 460p plus a 3p dividend.
Archives
HBI 2022: How digitalisation is driving a service revolution
The arguments for digitalisation in healthcare services are well-established, and thanks to the pandemic, hybrid models are coming more and more to the fore. How is digitalisation being used to improve financial outcomes, and how is data being used to deliver unprecedented proactive and preventative measures?
July 8, 2022
HBI 2022: Unlocking the true potential of AI
How can AI improve health outcomes? A panel at HBI 2022 entitled “The Truth about AI” presented solutions, and success rates that caught the eye.
July 8, 2022
HBI 2022: Money alone isn’t the solution to the workforce crisis
There is a global war for talent being keenly fought. Workforce is one of - if not the - most pressing problems in the healthcare sector. Providers at HBI 2022 uniformly fretted over the need to acquire, and retain staff, and shared their views on how best to do this.
July 8, 2022
HBI 2022: Partnering with university hospitals
University hospitals and their twinned research institutes are the mainstay of health care delivery in EMEA. Their approach to partnering is becoming increasingly sophisticated. Here we look at what they want and at winning partnering strategies that create real value and innovation.
July 7, 2022
New pricing engine allows Spire to capitalise on self-pay
Spire Healthcare, one of the UK’s largest private hospital groups, unveiled its new ‘pricing engine’ at their capital markets day this week - a computer programme which calculates optimal prices based on data about competitor pricing, procedures, inflation, and location, to automate price changes much quicker than was possible previously.
July 1, 2022
HBI Deals + Insights July 2022: Intelligence members
Click here to see your July 2022 issue of Deals + Insights This double size edition contains not only news from the month, but a summary of sessions at HBI 2022. Highlights include reports Fresenius could split off its hospital group to merge with a competitor, the latest developments in the €4bn proposed takeover of […]
July 1, 2022
Biogroup co-founder found dead in Paris, aged 52
Stéphane Eimer, president and co-founder of French laboratory company Biogroup, died on Wednesday, June 22.
June 24, 2022
Twenty things we learned at HBI 2022
HBI 2022, the year's largest CxO-level for-profit healthcare services conference, took place in central London this week. The conference stages and the floor were awash with interesting ideas, staggering statistics, suggestions for building a better business and the buzz of new friendships being formed. As always, there were new things to learn. Here are twenty of our top take aways from this year's event.
June 24, 2022
IHPN: Independent hospitals under used for NHS backlog
Independent hospital providers in the UK say its NHS is not sufficiently using its capacity to deal with the elective surgery backlog, despite saying it would do so.
June 24, 2022
Orpea may need to rebrand in Middle East expansion
Embattled French elderly care firm Orpea may need to rebrand its Middle East expansion, a source close to to the company tells HBI, but not everyone agrees.
June 24, 2022
Atrys buys Bienzobas for €76.3m
Despite its recent share price falls, highly acquisitive Spanish laboratory diagnostic group Atrys Health is to buy Bienzobas for €76.3m, a Spanish company which provides oncology services to insurance companies and hospital groups.
